WA BioBriefing with ASX – 4 June 2025
Listing, Compliance and Capital Raising for Public Biotechs
This insightful BioBriefing event brings together experts in the public markets and biotech to discuss and reflect on the challenges, opportunities and requirements for an ASX-listed company in the life sciences sector. The session will address admission and post listing requirements, best practices relevant to the biotech sector, and what public equity investors consider when investing in listed companies.
Why attend? Hear directly from ASX Listings Compliance together with a panel of industry experts, as they discuss ASX’s admission requirements for biotech companies, ongoing compliance with ASX’s disclosure rules, and raising capital in the public markets. Attendees will have an opportunity to engage and ask questions about the information provided. Following the session, we invite you to stay for networking drinks.
Who should attend: The session is open to all, however will be most relevant to pre-IPO candidates and ASX-listed entity staff with obligations relating to the entity’s ASX listing. Additionally, advisers to ASX-listed entities in the healthcare and life sciences sectors.
Drinks and nibbles are being generously provided by our host partner ASX.
Date:
Wednesday 4 June 2025
Time: (AWST)
4.45pm – 5.15pm Registrations open
5.15pm – 6.30pm BioBriefing (Presentations/Education Session)
6.30pm – 7.30pm BioCheers Networking Function
Venue:
ASX Central Park,
152-158 St George Terrace,
Perth WA 6000
Cost:
AusBiotech Members and ASX-Listed companies: Free
Non-member Attendees: $100.00